Carmat
CARMAT is a MedTech that designs, manufactures and markets the Aeson artificial heart. Learn more
Launch date
Employees
Market cap
$84.4m
Enterprise valuation
$136m (Public information from Sep 2024)
Share price
€1.792 ALCAR.PA
Company register number 504937905
Vélizy-Villacoublay Île-de-France (HQ)
Financials
Estimates*
| EUR | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | - | 2.3m | <1m | 2.8m | 14.7m | 36.1m | 81.6m |
| % growth | - | - | (84 %) | 666 % | 417 % | 145 % | 126 % |
| EBITDA | (20.6m) | (39.7m) | (45.7m) | (34.7m) | (36.0m) | (25.3m) | (15.2m) |
| % EBITDA margin | - | (1698 %) | (12289 %) | (1220 %) | (244 %) | (70 %) | (19 %) |
| Profit | (37.0m) | (61.9m) | (53.7m) | (53.9m) | (40.8m) | (32.1m) | (19.3m) |
| % profit margin | - | (2646 %) | (14430 %) | (1891 %) | (277 %) | (89 %) | (24 %) |
| EV / revenue | - | 139.1x | 559.4x | 75.6x | 9.8x | 5.2x | 2.6x |
| EV / EBITDA | -17.6x | -8.2x | -4.5x | -6.2x | -4.0x | -7.4x | -13.9x |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Seed | ||
| N/A | €5.0m | IPO | |
€50.0m | Post IPO Equity | ||
* | €30.0m | Post IPO Debt | |
| N/A | €60.0m | Post IPO Equity | |
| N/A | €55.7m | Post IPO Equity | |
* | N/A | €40.5m | Post IPO Equity |
€2.5m | Grant | ||
* | N/A | €31.1m | Post IPO Equity |
* | €7.9m | Grant | |
* | €5.3m | Post IPO Debt | |
* | N/A | €7.0m | Post IPO Equity |
* | N/A | €16.0m | Post IPO Equity |
* | N/A | €2.2m | Post IPO Equity |
| Total Funding | $11.4m | ||
Related Content
Recent News about Carmat
EditMore about Carmatinfo icon
EditCarmat is a France-based company engaged in the development and production of heart prosthesis. It engages in the development of implantable orthotopic and biocompatible artificial heart organs for the treatment of heart failure patients. The company also develops the product's power supply system and its control and remote diagnosis systems.
Keywords: Healthcare Devices / Services / Supplies, Technology Hardware, Transplantation, Cardiac And Cardiovascular Systems, Medical Devices.
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.